Stay updated on Combo Study of SV-BR-1-GM With Retifanlimab Clinical Trial

Sign up to get notified when there's something new on the Combo Study of SV-BR-1-GM With Retifanlimab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Combo Study of SV-BR-1-GM With Retifanlimab Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The study status was updated from enrollment by invitation to Completed, with the completion date recorded as 2026-03-24 and the update posted 2026-03-27. The enrollment-by-invitation note and related estimated dates were removed.
    Difference
    0.5%
    Check dated 2026-04-01T21:20:30.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0 on the page. This indicates a newer version of the study details page.
    Difference
    0.0%
    Check dated 2026-03-25T17:54:28.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T14:04:58.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    The page now shows a new site revision label (v3.4.2). An older government funding maintenance notice has been removed; no study content or data is changed.
    Difference
    0.4%
    Check dated 2026-02-11T02:36:17.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page now shows a site-wide funding-status notice and updates the version to v3.4.1 (replacing v3.4.0), with no changes to study-specific content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-03T23:45:25.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Added Show glossary and Revision: v3.4.0. Removed the older QC label variant 'Last Update Submitted that met QC Criteria' (lowercase), 'No FEAR Act data', and the revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-27T23:51:01.000Z thumbnail image

Stay in the know with updates to Combo Study of SV-BR-1-GM With Retifanlimab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Combo Study of SV-BR-1-GM With Retifanlimab Clinical Trial page.